267 related articles for article (PubMed ID: 24795344)
1. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
[TBL] [Abstract][Full Text] [Related]
2. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
[TBL] [Abstract][Full Text] [Related]
3. Enhanced closed-state inactivation of mutant cardiac sodium channels (SCN5A N1541D and R1632C) through different mechanisms.
Dharmawan T; Nakajima T; Iizuka T; Tamura S; Matsui H; Kaneko Y; Kurabayashi M
J Mol Cell Cardiol; 2019 May; 130():88-95. PubMed ID: 30935997
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
[TBL] [Abstract][Full Text] [Related]
5. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
[TBL] [Abstract][Full Text] [Related]
6. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
7. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
9. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
10. Inter-Regulation of K
Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
[TBL] [Abstract][Full Text] [Related]
11. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
[TBL] [Abstract][Full Text] [Related]
12. The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome.
Zheng J; Zhou F; Su T; Huang L; Wu Y; Yin K; Wu Q; Tang S; Makielski JC; Cheng J
Medicine (Baltimore); 2016 Jun; 95(23):e3836. PubMed ID: 27281089
[TBL] [Abstract][Full Text] [Related]
13. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
[TBL] [Abstract][Full Text] [Related]
14. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
[TBL] [Abstract][Full Text] [Related]
15. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
[TBL] [Abstract][Full Text] [Related]
16. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
[TBL] [Abstract][Full Text] [Related]
18. Relationship between sodium channel function and clinical phenotype in SCN5A variants associated with Brugada syndrome.
Pearman CM; Denham NC; Mills RW; Ding WY; Modi SS; Hall MCS; Todd DM; Mahida S
Hum Mutat; 2020 Dec; 41(12):2195-2204. PubMed ID: 33131149
[TBL] [Abstract][Full Text] [Related]
19. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
